Newron Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference in New York

PRESS RELEASE: Newron Pharmaceuticals S.p.A. ("Newron") [Ticker: SIX: NWRN], a research and development company focused on novel central nervous system (CNS) and pain therapies, today announced that Stefan Weber, CEO, will present at the 18th......